NEW YORK, February 28, 2022 /PRNewswire/ — The “Sequencing Reagents Market by Technology and Geography – Forecast and Analysis 2022-2026report has been added to Technavio’s offering. With ISO 9001:2015 certification, Technavio has proudly partnered with over 100 Fortune 500 companies for over 16 years.
The difference in potential growth for the sequencing reagents market between 2021 and 2026 is USD 4.09 billion. To get the exact annual growth variance and annual growth rate, Get a free sample report.
Key Market Dynamics:
-
market engine
-
Market challenges
Growing accessibility of DNA sequencing and growing demand for early diagnosis of genetic diseases are some of the major market drivers. However, factors such as insufficient resources for DNA sequencing in developing countries will challenge the growth of the market.
Learn more about additional key factors, trends and challenges available with Technavio. Read our FREE sample report now!
Analysis of key segments
The Sequencing Reagents Market report is segmented by Technology (Next Generation Sequencing, Sanger Sequencing, and Third Generation Sequencing) and Geography (North America, Europe, Asia, and Rest of the World (ROW)). North America will be the top region with 39% market growth over the forecast period. WE, Canada, GermanyUK and China are the key market for sequencing reagents in North America.
See our sample report for additional information on the contribution of all segments and regional opportunities in the report.
Supplier Information
The Sequencing Reagents market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
The increasing competition in the market forces the providers to adopt various growth strategies such as promotional activities and advertising expenditures to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as mergers and acquisitions to stay competitive in the market.
The report analyzes the competitive landscape of the market and offers information about several vendors in the market including:
-
BGI Group
-
BioChain Institute Inc.
-
F. Hoffmann La Roche Ltd.
-
Fluidigm Corp.
-
FroggaBio Inc.
-
Illumina Inc.
-
LGC Biosearch Technologies
-
Meridian Bioscience Inc.
-
New England Biolabs Inc.
-
Oxford Nanopore Technologies plc
-
Perkin Elmer Inc.
-
QIAGEN AG
-
Thermo Fisher Scientific Inc.
-
Tecan Group Ltd.
-
Trilink Biotechnology
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Read a free sample report.
Customize your report
Don’t miss the opportunity to talk to our analyst and learn more about this market report. Our analysts can also help you customize this report to suit your needs. Our analysts and industry experts will work directly with you to understand your needs and deliver personalized data in a short period of time.
We offer $1,000 FREE personalization value at time of purchase. Talk to our analyst now!
Related reports:
Escherichia Coli Testing Market by Type and Geography – Forecast and Analysis 2022-2026
Food Safety Testing Market by Application and Geography – Forecast and Analysis 2022-2026
Scope of Sequencing Reagents Market |
|
Report cover |
Details |
Page number |
120 |
Year of reference |
2021 |
Forecast period |
2022-2026 |
Growth momentum and CAGR |
Accelerate at a CAGR of 12.32% |
Market Growth 2022-2026 |
$4.09 billion |
Market structure |
Fragmented |
Annual growth (%) |
11.54 |
Regional analysis |
North America, Europe, Asia and Rest of the World (ROW) |
Successful market contribution |
North America at 39% |
Main consumer countries |
United States, Canada, Germany, United Kingdom and China |
Competitive landscape |
Leading Companies, Competitive Strategies, Consumer Engagement Reach |
Profiled Key Companies |
Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Meridian Bioscience Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc., Tecan Group Ltd., Trilink Biotechnologies, Merck KGaA, Pacific Biosciences of California Inc. and Takara Bio Inc. |
Market dynamics |
Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID-19 Impact and Recovery Analysis and Future Consumer Dynamics, Market Status Analysis market for the forecast period |
Personalization area |
If our report does not include the data you are looking for, you can contact our analysts and customize the segments. |
Contents
1. Summary
2 Market landscape
3 Market sizing
4 Five forces analysis
5 Market Segmentation by Technology
6 Customer Landscape
7 Geographic landscape
8 drivers, challenges and trends
9 Supplier landscape
10 Vendor Analysis
11 Appendix
About Us:
Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/
Show original content to download multimedia:https://www.prnewswire.com/news-releases/sequencing-reagents-market—2022-2026–increasing-affordability-of-dna-sequencing-to-boost-market-growth–17-000- technavio-research-reports-301490680.html
SOURCETechnavio